Skip to content

Simplexa COVID-19 Direct MOL4150

by DiaSorin Molecular LLC

Ref MOL4150

Simplexa COVID-19 Direct MOL4150 is a SARS-CoV-2 nucleic acid IVD (EU IVDD general IVD; FDA Class II; FDA product code QQX, Respiratory Specimen Nucleic Acid Sars-Cov-2 Test) made by DiaSorin Molecular LLC, registered in EUDAMED on 20 Oct 2026 (Basic UDI-DI B-20816101027020) and listed in FDA GUDID since 16 Jun 2023 (UDI-DI 20816101027020), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-20816101027020 Basic UDI-DI 20816101027020UDI-DIDate20 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number20816101027020 UDI-DI Date16 Jun 2023ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-20816101027020 registered 20 Oct 2026 Active
  • FDA GUDID UDI-DI 20816101027020 listed 16 Jun 2023 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 20816101027020
  2. Registered EUDAMED B-20816101027020

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Simplexa™ COVID-19 Direct EUDAMED
Simplexa COVID-19 Direct GUDID
Generic name
SARS-CoV-2 nucleic acid IVD, control
Model / Ref / Catalog
MOL4150
Primary DI / UDI-DI
20816101027020
Basic UDI-DI
B-20816101027020
FDA product code
QQX
EMDN code
W0105041106 Coronavirus - na reagents
GMDN term
SARS-CoV-2 nucleic acid IVD, control
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.3981
EU registration type
Legacy device (under a directive)
EU market of registration
Italy
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CORONAVIRUS - NA REAGENTS.

Other devices from DiaSorin Molecular LLC

See all devices from DiaSorin Molecular LLC →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)